Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Clinical trial NCT00923130 · COMPLETED

Trial details

NCT number: NCT00923130
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2009-01-07
Primary completion: 2016-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.